Skip to main content
Top
Published in: Clinical Rheumatology 4/2024

26-02-2024 | Dermatomyositis | CLINICAL IMAGE

Asymmetric darkened knuckles with subclinical myopathy revealed anti-Mi2b positive dermatomyositis

Author: Ritasman Baisya

Published in: Clinical Rheumatology | Issue 4/2024

Login to get access

Excerpt

A 25-year-old female presented to the Rheumatology outpatient department with 1-year history of fatigue, arthralgia, and skin hyperpigmentation. She noticed a gradually progressing darker tone in her skin with significant blackish pigmentation of the knuckles for 6 months. She also complained of occasional myalgia and difficulty in getting up from the bed. On examination, she had blackish pigmentation on left finger knuckles and skin of fingertips. Her skin complexion had a blackish hue. Motor examination revealed mild neck and truncal weakness (neck power by manual muscle testing 8 (MMT8) method = 7/10) with preserved motor power in upper and lower limbs (MMT8 for all groups of muscles 9/10). There were no tender joints at the time of examination. Other systemic examinations were unremarkable. There was a suspicion of clinically amyopathic dermatomyositis (CADM). Muscle enzymes were normal and routine blood reports were unremarkable. Myositis profile showed anti-Mi2b antibody was strongly positive. This was a case of anti-Mi2b antibody-positive CADM presented with pigmentary lesions on knuckles (Fig. 1).
Literature
1.
go back to reference Srivastava A, Choudhary S (2020) Knuckle pigmentation as an early cutaneous sign of vitamin B12 deficiency: a case report. JNMA J Nepal Med Assoc 58(230):798–800PubMedPubMedCentral Srivastava A, Choudhary S (2020) Knuckle pigmentation as an early cutaneous sign of vitamin B12 deficiency: a case report. JNMA J Nepal Med Assoc 58(230):798–800PubMedPubMedCentral
2.
go back to reference Goupil J, Osbourne A, Shi L (2023) Amyopathic dermatomyositis manifesting with marked unilateral eyelid swelling and hyperpigmentation in a darker skin tone. AIM Clin Cases 2:e220990CrossRef Goupil J, Osbourne A, Shi L (2023) Amyopathic dermatomyositis manifesting with marked unilateral eyelid swelling and hyperpigmentation in a darker skin tone. AIM Clin Cases 2:e220990CrossRef
3.
go back to reference Gudipati A, Rifat S, Uppin M, Jabeen A, Mathukumalli NL, Yareeda S, Kayidhi S, Pyal A, Dhamne M, Reddy YM (2023) Comparison of muscle biopsy features with myositis autoantibodies in inflammatory myopathies: a pilot experience. Ann Indian Acad Neurol 26(4):408–418CrossRefPubMedPubMedCentral Gudipati A, Rifat S, Uppin M, Jabeen A, Mathukumalli NL, Yareeda S, Kayidhi S, Pyal A, Dhamne M, Reddy YM (2023) Comparison of muscle biopsy features with myositis autoantibodies in inflammatory myopathies: a pilot experience. Ann Indian Acad Neurol 26(4):408–418CrossRefPubMedPubMedCentral
4.
go back to reference Ghirardello A, Gatto M, Franco C, Zanatta E, Padoan R, Ienna L, Gallo N, Zen M, Lundberg IE, Mahler M, Doria A, Iaccarino L (2023) Detection of myositis autoantibodies by multi-analytic immunoassays in a large multicenter cohort of patients with definite idiopathic inflammatory myopathies. Diagnostics (Basel) 13(19):3080CrossRefPubMed Ghirardello A, Gatto M, Franco C, Zanatta E, Padoan R, Ienna L, Gallo N, Zen M, Lundberg IE, Mahler M, Doria A, Iaccarino L (2023) Detection of myositis autoantibodies by multi-analytic immunoassays in a large multicenter cohort of patients with definite idiopathic inflammatory myopathies. Diagnostics (Basel) 13(19):3080CrossRefPubMed
Metadata
Title
Asymmetric darkened knuckles with subclinical myopathy revealed anti-Mi2b positive dermatomyositis
Author
Ritasman Baisya
Publication date
26-02-2024
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 4/2024
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-024-06914-7

Other articles of this Issue 4/2024

Clinical Rheumatology 4/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine